JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells)
JWCAR029-003
Phase 1 mab completed
Quick answer
JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells) for Diffuse Large B Cell Lymphoma is a Phase 1 program (mab) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai University of Traditional Chinese Medicine
- Indication
- Diffuse Large B Cell Lymphoma
- Phase
- Phase 1
- Modality
- mab
- Status
- completed